ADC Therapeutics reported revenue of $19.25M and net income of -$16.57M for the quarter ended Jun 2026, up 2.2% year over year. This income statement covers 27 quarters of results from Dec 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | |||||||||||||||||||||||||||
| Revenue | 13.15M | 46.50M | 17.29M | 76.32M | 18.99M | 19.28M | 14.49M | 18.05M | 17.41M | 18.46M | 23.03M | 18.84M | 16.43M | 20.85M | 19.25M | ||||||||||||
| Cost of RevenueCost of Rev | 0.50M | 0.53M | 2.27M | 1.29M | 0.59M | 1.32M | 0.37M | 2.51M | 1.22M | 0.85M | 2.06M | 0.84M | 1.20M | 3.47M | 2.10M | ||||||||||||
| Gross Profit | 12.64M | 45.97M | 15.03M | 75.03M | 18.40M | 17.96M | 14.13M | 15.54M | 16.19M | 17.61M | 20.97M | 18.00M | 15.22M | 17.38M | 17.14M | ||||||||||||
| Operating items | |||||||||||||||||||||||||||
| Research & DevelopmentR&D | 36.80M | 48.95M | 48.54M | 41.68M | 39.48M | 31.34M | 27.08M | 25.73M | 24.30M | 32.50M | 28.93M | 30.09M | 26.80M | 19.88M | 17.37M | ||||||||||||
| Selling, General & AdministrativeSG&A | 16.59M | 19.01M | 18.24M | 19.62M | 15.14M | 12.00M | 9.62M | 12.03M | 10.24M | 10.00M | 9.96M | 8.82M | 8.33M | 9.90M | 9.70M | ||||||||||||
| Restructuring CostsRestructuring | 13.09M | 0.38M | 2.67M | ||||||||||||||||||||||||
| Other Operating ExpensesOther Opex | 17.55M | 18.90M | 19.93M | 18.14M | 15.94M | 15.59M | 13.94M | 13.90M | 11.92M | 11.52M | 12.61M | 10.98M | 11.89M | 16.32M | 14.92M | ||||||||||||
| Operating ExpensesOpex | 70.94M | 86.86M | 86.70M | 79.44M | 70.56M | 58.93M | 50.64M | 51.67M | 46.45M | 54.03M | 51.50M | 62.99M | 47.40M | 46.10M | 44.66M | ||||||||||||
| Operating IncomeOp. Inc | -57.79M | -40.36M | -69.41M | -3.11M | -51.57M | -39.65M | -36.15M | -33.61M | -29.04M | -35.56M | -28.46M | -44.15M | -30.97M | -25.25M | -25.41M | ||||||||||||
| EBIT | -57.79M | -40.36M | -69.41M | -3.11M | -51.57M | -39.65M | -36.15M | -33.61M | -29.04M | -35.56M | -28.46M | -44.15M | -30.97M | -25.25M | -25.41M | ||||||||||||
| Non-operating items | |||||||||||||||||||||||||||
| Non Operating Interest Expenses | 4.26M | 9.22M | 8.80M | 11.36M | 10.42M | 10.31M | 12.82M | 12.50M | 12.68M | 13.12M | 12.23M | 13.00M | 13.39M | 12.35M | 13.51M | ||||||||||||
| Interest & Investment IncomeInt & Inv Inc | 0.02M | 18.31M | 0.02M | 0.27M | 2.30M | 2.37M | 2.70M | 2.95M | 3.25M | 3.44M | 2.05M | 1.93M | 2.47M | 1.99M | 1.82M | ||||||||||||
| Other Non Operating IncomeOther Non Op Inc. | -13.61M | 22.53M | 12.88M | -48.20M | 17.47M | 0.04M | -5.07M | 0.86M | 5.23M | -2.60M | 2.75M | 1.62M | -0.74M | 0.20M | -0.18M | 0.93M | -0.98M | 2.63M | 20.54M | ||||||||
| Non Operating IncomeNon Op. Inc. | -9.36M | 13.44M | 12.88M | -37.12M | -0.00M | -13.00M | -9.25M | -12.14M | -6.67M | -8.05M | -9.97M | -11.24M | -10.00M | -7.72M | 8.85M | ||||||||||||
| Net income details | |||||||||||||||||||||||||||
| EBT | -71.40M | -17.83M | -65.32M | -51.32M | -59.69M | -52.70M | -45.40M | -45.80M | -35.71M | -43.62M | -38.44M | -55.39M | -40.97M | -32.97M | -16.57M | ||||||||||||
| Tax ProvisionsTaxes | 0.14M | -1.17M | -0.95M | -0.71M | -0.26M | -4.50M | -0.10M | 0.20M | 0.23M | 0.09M | 0.17M | 1.25M | |||||||||||||||
| Profit After TaxPAT | -71.55M | -34.38M | -16.66M | -64.37M | -50.61M | -25.48M | -59.53M | -48.92M | -46.73M | -86.95M | -46.61M | -36.54M | -43.97M | -32.06M | -38.60M | -56.65M | -40.97M | -6.41M | -32.97M | -16.57M | |||||||
| Equity Income | -0.77M | -1.41M | -2.43M | -0.69M | -0.60M | -0.26M | |||||||||||||||||||||
| Income from Continuing OperationsIncome (Continuing) | -71.55M | -16.66M | -64.37M | -50.61M | -59.43M | -48.20M | -45.30M | -46.00M | -35.95M | -43.71M | -38.60M | -56.65M | -40.97M | -32.97M | -16.57M | ||||||||||||
| Consolidated Net IncomeConsol Net Inc. | -71.55M | -16.66M | -64.37M | -50.61M | -59.43M | -48.20M | -45.30M | -46.00M | -35.95M | -43.71M | -38.60M | -56.65M | -40.97M | -32.97M | -16.57M | ||||||||||||
| Income towards Parent CompanyParent Net Inc | -71.55M | -16.66M | -64.37M | -50.61M | -59.43M | -48.20M | -45.30M | -46.00M | -35.95M | -43.71M | -38.60M | -56.65M | -40.97M | -32.97M | -16.57M | ||||||||||||
| Net Income towards Common StockholdersNet Income | -71.55M | -16.66M | -64.37M | -50.61M | -59.43M | -48.20M | -45.30M | -46.00M | -35.95M | -43.71M | -38.60M | -56.65M | -40.97M | -32.97M | -16.57M | ||||||||||||
| Additional items | |||||||||||||||||||||||||||
| EPS (Basic) | -1.09 | -0.22 | -0.84 | -0.66 | -0.74 | -0.59 | -0.55 | -0.56 | -0.38 | -0.42 | -0.36 | -0.50 | -0.30 | -0.21 | -0.11 | ||||||||||||
| EPS (Diluted) | -0.74 | -0.59 | -0.55 | -0.56 | -0.38 | -0.42 | -0.36 | -0.50 | -0.30 | -0.21 | -0.11 | ||||||||||||||||
| Shares Outstanding | 65.41M | 76.75M | 76.75M | 76.75M | 76.75M | 78.15M | 80.81M | 81.47M | 82.26M | 81.71M | 82.55M | 95.69M | 104.82M | 97.16M | 107.20M | 113.74M | 136.45M | 127.07M | 154.14M | 155.02M | |||||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 78.15M | 80.81M | 81.47M | 82.26M | 81.71M | 82.55M | 95.69M | 104.82M | 97.16M | 107.20M | 113.74M | 136.45M | 127.07M | 154.14M | 155.02M | ||||||||||||
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 76.81M | 80.64M | 89.04M | 89.04M | 89.04M | 82.29M | 82.78M | 96.47M | 96.69M | 98.86M | 99.18M | 112.50M | 112.63M | 125.75M | 127.17M | 127.44M | |||||||||||
| EBITDA | -57.79M | -40.36M | -69.41M | -3.11M | -51.57M | -39.65M | -36.15M | -33.61M | -29.04M | -35.56M | -28.46M | -44.15M | -30.97M | -25.25M | -25.41M | ||||||||||||
| Interest ExpensesInt Expense | 4.26M | 9.22M | 8.80M | 11.36M | 10.42M | 10.31M | 12.82M | 12.50M | 12.68M | 13.12M | 12.23M | 13.00M | 13.39M | 12.35M | 13.51M | ||||||||||||
| Tax Rate | -0.20% | 6.56% | 1.45% | 1.39% | 0.44% | 8.54% | 0.22% | -0.44% | -0.66% | -0.21% | -0.43% | -2.26% |